Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies.

Moreau, Philippe; Mateos, María-Victoria; Goldschmidt, Hartmut; Esther Gonzalez Garcia, Maria; Besemer, Britta; Sonia Gonzalez Perez, Marta; Mohty, Mohamad; Lindsey-Hill, Joanne; Kirkpatrick, Suriya; Delforge, Michel; Angelucci, Emanuele; Di Raimondo, Francesco; Vij, Ravi; Doyle, Margaret; Gray, Kathleen; Albrecht, Claire; Strulev, Vadim; Haddad, Imène; Koskinen, Silva; Acciarri, Lorenzo; Buyze, Jozefien; Weisel, Katja

doi:10.1016/j.clml.2025.03.014

Public

Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies.

Shared by NobleBlocks on Sep 1, 2025 • 12:00 AM UTC

Authors:

Philippe Moreau

María-Victoria Mateos

Hartmut Goldschmidt

Abstract

BACKGROUND: Patients with relapsed/refractory multiple myeloma (RRMM) who develop extramedullary disease (EMD) generally have a poor prognosis, highlighting the urgent need for new therapies. We report effectiveness outcomes and safety in patients with and without EMD from the pooled analysis of Loc...

Subject

Extramedullary plasmacytoma

Prospective

Real-life outcomes

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!